Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Sep;92(3):1262–1268. doi: 10.1172/JCI116698

X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

D G Bichet 1, M F Arthus 1, M Lonergan 1, G N Hendy 1, A J Paradis 1, T M Fujiwara 1, K Morgan 1, M C Gregory 1, W Rosenthal 1, A Didwania 1, et al.
PMCID: PMC288266  PMID: 8104196

Abstract

In X-linked nephrogenic diabetes insipidus (NDI) the urine of male patients is not concentrated after the administration of the antidiuretic hormone arginine-vasopressin. This disease is due to mutations in the V2 receptor gene that maps to chromosome region Xq28. In 1969, Bode and Crawford suggested that most NDI patients in North America shared common ancestors of Ulster Scot immigrants who arrived in Halifax in 1761 on the ship Hopewell. A link between this family and a large Utah kindred was also suggested. DNA was obtained from 17 affected male patients from the "Hopewell" kindred and from four additional families from Nova Scotia and New Brunswick who shared the same Xq28 NDI haplotype. The Utah kindred and two families (Q2, Q3) from Quebec were also studied. The "Hopewell" mutation, W71X, is a single base substitution (G-->A) that changes codon 71 from TGG (tryptophan) to TGA (stop). The W71X mutation was found in affected members of the Hopewell and of the four satellite families. The W71X mutation is the cause of X-linked NDI for the largest number of related male patients living in North America. Other families (Utah, Q2 and Q3) that are historically and ethnically unrelated bear other mutations in the V2 receptor gene.

Full text

PDF
1262

Images in this article

1264Image
on p.1264
1264Image
on p.1264
1265Image
on p.1265
1265Image
on p.1265
1265Image
on p.1265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianchine J. W., Stambler A. A., Harrison H. E. Nephrogenic (vasopressin-resistant) diabetes insipidus with the usual X-linked inheritance. Birth Defects Orig Artic Ser. 1971 May;7(6):280–281. [PubMed] [Google Scholar]
  2. Bichet D. G., Hendy G. N., Lonergan M., Arthus M. F., Ligier S., Pausova Z., Kluge R., Zingg H., Saenger P., Oppenheimer E. X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies. Am J Hum Genet. 1992 Nov;51(5):1089–1102. [PMC free article] [PubMed] [Google Scholar]
  3. Bichet D. G., Razi M., Arthus M. F., Lonergan M., Tittley P., Smiley R. K., Rock G., Hirsch D. J. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism. Kidney Int. 1989 Nov;36(5):859–866. doi: 10.1038/ki.1989.272. [DOI] [PubMed] [Google Scholar]
  4. Bichet D. G., Razi M., Lonergan M., Arthus M. F., Papukna V., Kortas C., Barjon J. N. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med. 1988 Apr 7;318(14):881–887. doi: 10.1056/NEJM198804073181403. [DOI] [PubMed] [Google Scholar]
  5. Birnbaumer M., Seibold A., Gilbert S., Ishido M., Barberis C., Antaramian A., Brabet P., Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature. 1992 May 28;357(6376):333–335. doi: 10.1038/357333a0. [DOI] [PubMed] [Google Scholar]
  6. Bode H. H., Crawford J. D. Nephrogenic diabetes insipidus in North America. The Hopewell hypothesis. N Engl J Med. 1969 Apr 3;280(14):750–754. doi: 10.1056/NEJM196904032801404. [DOI] [PubMed] [Google Scholar]
  7. CANNON J. F. Diabetes insipidus; clinical and experimental studies with consideration of genetic relationships. AMA Arch Intern Med. 1955 Aug;96(2):215–272. doi: 10.1001/archinte.1955.00250130089012. [DOI] [PubMed] [Google Scholar]
  8. Feigin R. D., Rimoin D. L., Kaufman R. L. Nephrogenic diabetes insipidus in a Negro kindred. Am J Dis Child. 1970 Jul;120(1):64–68. doi: 10.1001/archpedi.1970.02100060098016. [DOI] [PubMed] [Google Scholar]
  9. Forssman H. The recognition of nephrogenic diabetes insipidus. A very small page from the history of medicine. Acta Med Scand. 1975 Jan-Feb;197(1-2):1–6. doi: 10.1111/j.0954-6820.1975.tb04869.x. [DOI] [PubMed] [Google Scholar]
  10. Jans D. A., van Oost B. A., Ropers H. H., Fahrenholz F. Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors. J Biol Chem. 1990 Sep 15;265(26):15379–15382. [PubMed] [Google Scholar]
  11. Kambouris M., Dlouhy S. R., Trofatter J. A., Conneally P. M., Hodes M. E. Localization of the gene for X-linked nephrogenic diabetes insipidus to Xq28. Am J Med Genet. 1988 Jan;29(1):239–246. doi: 10.1002/ajmg.1320290138. [DOI] [PubMed] [Google Scholar]
  12. Knoers N., van der Heyden H., van Oost B. A., Monnens L., Willems J., Ropers H. H. Three-point linkage analysis using multiple DNA polymorphic markers in families with X-linked nephrogenic diabetes insipidus. Genomics. 1989 Apr;4(3):434–437. doi: 10.1016/0888-7543(89)90352-2. [DOI] [PubMed] [Google Scholar]
  13. Kobilka B. K., Kobilka T. S., Daniel K., Regan J. W., Caron M. G., Lefkowitz R. J. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science. 1988 Jun 3;240(4857):1310–1316. doi: 10.1126/science.2836950. [DOI] [PubMed] [Google Scholar]
  14. Libber S., Harrison H., Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr. 1986 Feb;108(2):305–311. doi: 10.1016/s0022-3476(86)81010-1. [DOI] [PubMed] [Google Scholar]
  15. Lolait S. J., O'Carroll A. M., McBride O. W., Konig M., Morel A., Brownstein M. J. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature. 1992 May 28;357(6376):336–339. doi: 10.1038/357336a0. [DOI] [PubMed] [Google Scholar]
  16. Merendino J. J., Jr, Speigel A. M., Crawford J. D., O'Carroll A. M., Brownstein M. J., Lolait S. J. Brief report: a mutation in the vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. N Engl J Med. 1993 May 27;328(21):1538–1541. doi: 10.1056/NEJM199305273282106. [DOI] [PubMed] [Google Scholar]
  17. Ostrowski J., Kjelsberg M. A., Caron M. G., Lefkowitz R. J. Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. Annu Rev Pharmacol Toxicol. 1992;32:167–183. doi: 10.1146/annurev.pa.32.040192.001123. [DOI] [PubMed] [Google Scholar]
  18. Pan Y., Metzenberg A., Das S., Jing B., Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet. 1992 Oct;2(2):103–106. doi: 10.1038/ng1092-103. [DOI] [PubMed] [Google Scholar]
  19. Rosenthal W., Seibold A., Antaramian A., Lonergan M., Arthus M. F., Hendy G. N., Birnbaumer M., Bichet D. G. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature. 1992 Sep 17;359(6392):233–235. doi: 10.1038/359233a0. [DOI] [PubMed] [Google Scholar]
  20. Savarese T. M., Fraser C. M. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J. 1992 Apr 1;283(Pt 1):1–19. doi: 10.1042/bj2830001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schultz P., Lines D. R. Nephrogenic diabetes insipidus in an Australian aboriginal kindred. Humangenetik. 1975;26(1):79–85. doi: 10.1007/BF00280288. [DOI] [PubMed] [Google Scholar]
  22. Seibold A., Brabet P., Rosenthal W., Birnbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet. 1992 Nov;51(5):1078–1083. [PMC free article] [PubMed] [Google Scholar]
  23. Sharif M., Hanley M. R. Peptide receptors. Stepping up the pressure. Nature. 1992 May 28;357(6376):279–280. doi: 10.1038/357279a0. [DOI] [PubMed] [Google Scholar]
  24. Tsui L. C. Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium. Hum Mutat. 1992;1(3):197–203. doi: 10.1002/humu.1380010304. [DOI] [PubMed] [Google Scholar]
  25. WALKER N. F., RANCE C. P. Inheritance of nephrogenic diabetes insipidus. Am J Hum Genet. 1954 Sep;6(3):354–358. [PMC free article] [PubMed] [Google Scholar]
  26. van den Ouweland A. M., Dreesen J. C., Verdijk M., Knoers N. V., Monnens L. A., Rocchi M., van Oost B. A. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet. 1992 Oct;2(2):99–102. doi: 10.1038/ng1092-99. [DOI] [PubMed] [Google Scholar]
  27. van den Ouweland A. M., Knoop M. T., Knoers V. V., Markslag P. W., Rocchi M., Warren S. T., Ropers H. H., Fahrenholz F., Monnens L. A., van Oost B. A. Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics. 1992 Aug;13(4):1350–1352. doi: 10.1016/0888-7543(92)90067-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES